CRINETICS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48 USD | -2.87% |
|
+1.69% | +34.91% |
| May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
| May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -2.87% | +1.69% | +34.91% | +117.10% | +84.69% | 3.78B |  | | |
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Relative Strength Chart
